EMA seeks executive director

Andreas Pott will be acting executive director until position is filled

The European Medicines Agency (EMA) is seeking a new executive director. Its current head, Thomas Lönngren, is leaving the post on 31 December, following the end of his second five-year mandate.

While EMA searches for a permanent replacement, its current head of administration, Andreas Pott, will serve as acting executive director.

University of Hamburg graduate, Pott has been the agency’s administration chief since 2000, having previously worked for the European Parliament and the EU’s translation service.

Swede Lönngren is a former deputy director-general of the Swedish Medical Products Agency (MPA).

You may also like

Manufacturing

Bracco enters cell therapy manufacturing with microbubble-based cell selection technology

Bracco Imaging is expanding into cell therapy manufacturing with a bead-free cell selection and activation technology based on its clinically validated microbubble platform
Medical Devices

Biocomposites gains MDR certification for STIMULAN antibiotic carriers

Biocomposites has secured EU MDR certification for its STIMULAN Rapid Cure and STIMULAN Kit products, enabling them to be mixed with multiple Gram-positive and Gram-negative antibiotics for infection management in bone and soft tissue
Pharma 5.0

New computational approaches could pave the way for safer medicines with fewer side effects

Advances in computational modelling and artificial intelligence are offering new ways to understand why medicines cause side effects and how to avoid them in future drug development
Digital

Shimadzu introduces a new site for its portfolio of LIB solutions

The website especially targets battery cell manufacturers, e-vehicle OEMs, research institutions as well as recycling companies and start-ups. There they will find Shimadzu’s latest solutions in the LIB market, including in-depth background information such as brochures and FAQs as well as featured highlight products
Hi Tech Manufacturing

Sustainable temperature control solutions at Analytica 2026

The presentation will highlight innovative equipment for laboratory and analytical applications
Medical Devices

Abbott hit with multiple FDA complaints in warning letter

The FreeStyle Libre manufacturer has been in the agency's line of fire after it deemed the company's response to previous letters "inadequate"
Sustainability

DFE Pharma launches EcoLact 2030 for verifiable sustainability of lactose portfolio

The company is the first pharmaceutical excipient organisation to offer a lactose portfolio with accelerated 30% CO2 reduction for pharmaceutical manufacturers’ sustainability reporting
Subscribe now